How many institutions held OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in Q2 2018?

47 institutional investors reported OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share for Q2 2018. Use the holders table for investor-level position and value details.

Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)

Q: What does CUSIP 690469101 represent in this 13F holders report?

CUSIP 690469101 is the security identifier for OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 690469101

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 134,553,130
Total 13F shares: 7,653,221
Share change: +606,358
Total reported value: $59,692,116
Price per share: $7.80
Number of holders: 47
Value change: +$4,811,013
Number of buys: 28
Number of sells: 19

Quarterly Holders Quick Answers

What is CUSIP 690469101?
CUSIP 690469101 identifies OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 690469101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	1%	1,385,066	$9,792,000	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	1%	1,358,459	$9,606,000	—	31 Mar 2018	13F
JENNISON ASSOCIATES LLC	13F	Company	0.48%	650,656	$4,600,000	—	31 Mar 2018	13F
Tekla Capital Management LLC	13F	Company	0.4%	535,824	$3,788,000	—	31 Mar 2018	13F
OppenheimerFunds, Inc.	13F	Company	0.32%	424,170	$2,999,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	0.3%	400,530	$2,832,000	—	31 Mar 2018	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.22%	300,480	$2,124,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.22%	295,722	$2,089,000	—	31 Mar 2018	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.21%	283,918	$2,007,000	—	31 Mar 2018	13F
BAKER BROS. ADVISORS LP	13F	Company	0.18%	247,733	$1,751,000	—	31 Mar 2018	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.15%	207,552	$1,467,000	—	31 Mar 2018	13F
Redmile Group, LLC	13F	Company	0.12%	160,718	$1,136,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	0.09%	118,430	$837,000	—	31 Mar 2018	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.08%	108,440	$767,000	—	31 Mar 2018	13F
STATE STREET CORP	13F	Company	0.08%	105,728	$747,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.04%	59,344	$420,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.04%	50,019	$353,000	—	31 Mar 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.03%	34,295	$243,000	—	31 Mar 2018	13F
JPMORGAN CHASE & CO	13F	Company	0.02%	33,006	$233,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0.02%	27,671	$196,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	0.02%	25,388	$180,000	—	31 Mar 2018	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.02%	20,520	$145,000	—	31 Mar 2018	13F
Spark Investment Management LLC	13F	Company	0.01%	19,800	$139,000	—	31 Mar 2018	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	18,676	$132,000	—	31 Mar 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.01%	16,889	$119,000	—	31 Mar 2018	13F
DRW Securities, LLC	13F	Company	0.01%	15,317	$108,000	—	31 Mar 2018	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.01%	15,012	$106,000	—	31 Mar 2018	13F
Creative Planning	13F	Company	0.01%	14,932	$106,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.01%	14,866	$105,000	—	31 Mar 2018	13F
TD ASSET MANAGEMENT INC	13F	Company	0.01%	13,580	$96,000	—	31 Mar 2018	13F
Virtu Financial LLC	13F	Company	0.01%	13,433	$95,000	—	31 Mar 2018	13F
Trexquant Investment LP	13F	Company	0.01%	12,242	$87,000	—	31 Mar 2018	13F
Granite Point Capital Management, L.P.	13F	Company	0.01%	12,200	$86,000	—	31 Mar 2018	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	7,900	$56,000	—	31 Mar 2018	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	7,840	$55,000	—	31 Mar 2018	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.01%	7,435	$52,000	—	31 Mar 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	6,838	$48,000	—	31 Mar 2018	13F
STRS OHIO	13F	Company	0%	3,500	$24,000	—	31 Mar 2018	13F
ROYAL BANK OF CANADA	13F	Company	0%	2,792	$20,000	—	31 Mar 2018	13F
BARCLAYS PLC	13F	Company	0%	2,538	$18,000	—	31 Mar 2018	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	2,306	$16,303	—	31 Mar 2018	13F
Legal & General Group Plc	13F	Company	0%	2,145	$15,000	—	31 Mar 2018	13F
CITIGROUP INC	13F	Company	0%	1,460	$10,000	—	31 Mar 2018	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0%	1,011	$7,000	—	31 Mar 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	908	$6,000	—	31 Mar 2018	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	724	$5,000	—	31 Mar 2018	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	443	$3,000	—	31 Mar 2018	13F
MEEDER ASSET MANAGEMENT INC	13F	Company	0%	291	$2,000	—	31 Mar 2018	13F

Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q2 2018

As of 30 Jun 2018, Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by 47 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,653,221 shares. The largest 10 holders included BlackRock Inc., FMR LLC, COWEN INC., Tekla Capital Management LLC, VANGUARD GROUP INC, OppenheimerFunds, Inc., JENNISON ASSOCIATES LLC, DEUTSCHE BANK AG\, DRIEHAUS CAPITAL MANAGEMENT LLC, and Granite Point Capital Management, L.P.. This page lists 47 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

Holder diff

-1

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.